TOWNSEND RICHARD NOLAN (Chief Executive Officer) sold 1.0% of their position (3.34K shares) of LEXEO THERAPEUTICS, INC. on the open market
Open‑market sale worth $16.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/20/2026ACC: 0001995218-26-000011
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-3.34K
Net shares
Net seller
$16.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.34K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.34K
Price / share
$5.06
Trade value
$16.93K
% of position
1.0%
5/18/2026
340.11K→336.76K
Total
Net shares
−3.34K
Net value
-$16.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/18/2026 | S · Sale | −3.34K | $5.06 | $16.93K | 1.0% | 340.11K | 336.76K |
| Total | −3.34K | -$16.93K | ||||||
Derivative Transactions0
No derivative transactions reported